— Know what they know.
Not Investment Advice
Also trades as: GLTO (NASDAQ) · $vol 5M

DMRA NASDAQ

Damora Therapeutics, Inc.
1W: -0.1% 1M: -26.7% 3M: -30.7% YTD: -13.7%
$20.65
+0.42 (+2.08%)
 
Weekly Expected Move ±11.4%
$16 $18 $21 $23 $25
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 32 · $1.3B mcap · 41M float · 1.47% daily turnover · Short 70% of daily vol

Supply Chain Overview

1 relationships
0
As Filer
counterparties named
1
As Counterparty
mentioned by others
2025-11-10
Earliest Filing
2025-11-10
Latest Filing

Mentioned As Counterparty

1 mentions

Other companies that named DMRA in their SEC 8-K filings.

Filed By Relationship Summary Filing Date SEC
GLTO Galecto, Inc. acquirer Target company acquired by Galecto, Inc. in a merger agreement. 2025-11-10 View
Recent 8-K Filings (4)
Filing Date Description Type SEC
2026-07-20 Material Agreement; Bylaws Amendment; Regulation FD; Exhibits Agreement View
2026-06-17 Shareholder Vote View
2026-05-04 Officer/Director Change; Exhibits View
2026-04-20 Accountant Change; Exhibits View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms